Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
International Journal of Cancer
|
December 3, 2014
Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management
Jack Cuzick, Orrin Myers, William C Hunt, et al.
JAMA Oncology
|
October 17, 2018
Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women
Megan A Clarke, Li C Cheung, Philip E Castle, et al.
Cancer Cytopathology
|
August 19, 2014
Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening
Nicolas Wentzensen, Barbara Fetterman, Diane Tokugawa, et al.
International Journal of Cancer
|
March 22, 2023
Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States
Jack Cuzick, Rachael Adcock, Walter Kinney, et al.
Obstetrics and Gynecology
|
October 8, 2021
Invasive Cervical Cancer After a Positive Pap Test Result and Negative Human Papillomavirus Test Result
Alexander Locke, Nina R Shah, Barbara Fetterman, et al.
Gynecologic Oncology
|
July 13, 2021
Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
Jack Cuzick, Ruofei Du, Rachael Adcock, et al.
Journal of Clinical Microbiology
|
November 15, 2011
Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests
Julia C Gage, Mark Sadorra, Brandon J Lamere, et al.
Journal of the National Cancer Institute
|
September 18, 2015
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
Nicolas Wentzensen, Barbara Fetterman, Philip E Castle, et al.
Gynecologic Oncology
|
February 1, 2024
Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California
Brian Befano, Nicolas Wentzensen, Thomas Lorey, et al.
International Journal of Cancer
|
March 7, 2020
A study of the risks of CIN3+ detection after multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California
Anne Hammer, Maria Demarco, Nicole Campos, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
International Journal of Cancer
|
December 3, 2014
Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management
Jack Cuzick, Orrin Myers, William C Hunt, et al.
JAMA Oncology
|
October 17, 2018
Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women
Megan A Clarke, Li C Cheung, Philip E Castle, et al.
Cancer Cytopathology
|
August 19, 2014
Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening
Nicolas Wentzensen, Barbara Fetterman, Diane Tokugawa, et al.
International Journal of Cancer
|
March 22, 2023
Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States
Jack Cuzick, Rachael Adcock, Walter Kinney, et al.
Obstetrics and Gynecology
|
October 8, 2021
Invasive Cervical Cancer After a Positive Pap Test Result and Negative Human Papillomavirus Test Result
Alexander Locke, Nina R Shah, Barbara Fetterman, et al.
Gynecologic Oncology
|
July 13, 2021
Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
Jack Cuzick, Ruofei Du, Rachael Adcock, et al.
Journal of Clinical Microbiology
|
November 15, 2011
Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests
Julia C Gage, Mark Sadorra, Brandon J Lamere, et al.
Journal of the National Cancer Institute
|
September 18, 2015
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
Nicolas Wentzensen, Barbara Fetterman, Philip E Castle, et al.
Gynecologic Oncology
|
February 1, 2024
Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California
Brian Befano, Nicolas Wentzensen, Thomas Lorey, et al.
International Journal of Cancer
|
March 7, 2020
A study of the risks of CIN3+ detection after multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California
Anne Hammer, Maria Demarco, Nicole Campos, et al.
Page
of 6